TUESDAY, Jan.9, 2024 (HealthDay News) — Patients with the most common form of pancreatic cancer could benefit from an experimental therapeutic vaccine, a small new clinical trial shows. The vaccine, called ELI-002 for now, is targeted to what are known as KRAS-mutated solid tumors. Over 90% of pancreatic tumors haveContinue Reading
WEDNESDAY, Jan. 3, 2024 — Numerous studies have confirmed that annual lung cancer screening using CT scans does save lives. However, new data has emerged showing that scans often pick up abnormalities that lead to follow-up invasive tests — and more complications. While no one is saying that all smokersContinue Reading
FRIDAY, Dec. 29, 2023 (HealthDay News) — More patients could benefit from immunotherapy, a highly effective treatment for some cancers, new research suggests. Revising current testing guidelines so that a more sophisticated test could be used more often would enable 6,000 more people in the United States to receive theContinue Reading
WEDNESDAY, Dec. 27, 2023 (HealthDay News) — Getting your preventive screening colonoscopy could be even more of a lifesaver than you thought, a new analysis finds. The two gold standard tests for spotting cancers and polyps of the colon — colonoscopy and sigmoidoscopy — offer double the benefit determined inContinue Reading
THURSDAY, Dec. 21, 2023 (HealthDay News) — Kids who’ve survived cancer face many health challenges, and a heightened risk for diabetes is one of them, new research shows. A team at St. Jude’s Children’s Hospital in Memphis, Tenn., reports that these children have twice the odds of developing prediabetes (aContinue Reading
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — Long left to the fringes of the recreational drug culture, psilocybin — the hallucinatory ingredient in “magic mushrooms” — has recently been making inroads as a legitimate (and fast-acting) antidepressant. Research published Dec. 18 in Cancer shows its benefits may extend to peopleContinue Reading
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression two years later. That’s the main finding from a study that tracked outcomes for 64 people treated forContinue Reading
TUESDAY, Dec. 19, 2023 (HealthDay News) — At-home tests for colon cancer make this important screening readily available to folks who can’t afford or would rather not go through a colonoscopy. Unfortunately, more than 1 in 10 at-home tests sent to a lab are unusable, mainly due to mistakes madeContinue Reading
FRIDAY, Dec. 15, 2023 (HealthDay News) — A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return afterContinue Reading
FRIDAY, Dec. 8, 2023 (HealthDay News) — Some women with a very early form of breast cancer known as ductal carcinoma in situ (DCIS) can safely skip follow-up radiation therapy after surgery, new research suggests. Results from a sophisticated genetic test are key to the decision to either undergo orContinue Reading